Deals > All

France Monaco Central France Eastern France Northern France Paris (region) Southern France Western France

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 2020 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Deal: Collaboration or Financing	Date
F2G Ltd–Novo Group: investment, 202208 financing round totalling $70m inc existing + co-investor Novo Holdings	2022-08-04
F2G Ltd–SEVERAL: investment, 202208 financing round $70m co-led by new investors Forbion + Sofinnova Partners	2022-08-04
F2G Ltd–Sofinnova: investment, 202208 financing round totalling $70m inc new + co-lead investor Sofinnova Partners	2022-08-04
Forty51 Ventures–Fischli Group: investment, 202207 first closing totalling $43m of Forty51 Ventures I fund incl co-lead investor Fischli Family	2022-07-18
Forty51 Ventures–OTHER: investment, 202207 first closing totalling $43m of Forty51 Ventures I fund incl biotech entrepreneures + private individuals	2022-07-18
Forty51 Ventures–SEVERAL: investment, 202207 first $43m closing of Forty51 Ventures I fund	2022-07-18
Forty51 Ventures–Stable Asset Management: investment, 202207 first closing totalling $43m of Forty51 Ventures I fund incl co-lead investor SAM	2022-07-18
Agomab Therapeutics–OTHER: investment, 202207 financing round Series B extension totalling $40.5m incl existing-investors	2022-07-13
Agomab Therapeutics–SEVERAL: investment, 202207 financing round Series B extension $40.5m led by Pfizer bringing total Series B to $114m	2022-07-13
Biosyntia–ECBF: investment, 202207 financing round Series B totalling €11.5m incl new + lead investor ECBF	2022-07-07
Biosyntia–Novo Group: investment, 202207 financing round Series B totalling €11.5m incl existing + co-investor Novo Seeds	2022-07-07
Biosyntia–SEVERAL: investment, 202207 financing round Series B €11.5m led by new investor ECBF	2022-07-07
Biosyntia–Sofinnova: investment, 202207 financing round Series B totalling €11.5m incl existing + co-investor Sofinnova Partners	2022-07-07
Ganymed Robotics–BNP Paribas: investment, 202207 financing round Series B first closing totalling €21m incl co-investor BNP Paribas Développement	2022-07-07
Ganymed Robotics–Cathay Capital: investment, 202207 financing round Series B first closing totalling €21m incl lead investor Cathay Health	2022-07-07
Ganymed Robotics–Crédit Mutuel-CIC: investment, 202207 financing round Series B first closing totalling €21m incl co-investor Crédit Mutuel Innovation	2022-07-07
Ganymed Robotics–Eurazeo: investment, 202207 financing round Series B first closing totalling €21m incl co-investor Kurma Partners	2022-07-07
Ganymed Robotics–OTHER: investment, 202207 financing round Series B first closing totalling €21m incl internationallly renowned surgeons	2022-07-07
Ganymed Robotics–SEVERAL: investment, 202207 financing round Series B first closing €21m led by Cathay Health	2022-07-07
Aurobac Therapeutics–Boehringer: investment, 202207 launch of €40m joint venture Aurobac incl €30m from lead investor Boehringer Ingelheim	2022-07-06
Boehringer–Evotec: investment, 202207 launch of €40m joint venture Aurobac incl €5m from co-investor Evotec	2022-07-06
Boehringer–Mérieux: investment, 202207 launch of €40m joint venture Aurobac incl €5m from co-investor bioMérieux	2022-07-06
Epizyme–Ipsen: investment, 202206– cash tender offer $247m + 1CVR/share ANNOUNCED	2022-06-27
Micropep Technologies–CEA Industrie: investment, 202206 financing round Series A1 totalling €8.75m incl existing + co-investor Supernova Invest	2022-06-27
Micropep Technologies–Fall Line Capital: investment, 202206 financing round Series A1 totalling €8.75m incl new + lead investor Fall Line Capital	2022-06-27
Micropep Technologies–FMC: investment, 202206 financing round Series A1 totalling €8.75m incl existing + co-investor FMC Ventures	2022-06-27
Micropep Technologies–Irdi Soridec: investment, 202206 financing round Series A1 totalling €8.75m incl existing + co-investor Irdi/Soridec	2022-06-27
Micropep Technologies–SEVERAL: investment, 202206 financing round Series A1 €8.75m led by new investor Fall Line Capital	2022-06-27
Micropep Technologies–Sofinnova: investment, 202206 financing round Series A1 totalling €8.75m incl existing + co-investor Sofinnova Partners	2022-06-27
Kranus Health–Karista: investment, 202206 financing round Series A totalling >$6.5m incl lead investor Karista	2022-06-20
Kranus Health–SEVERAL: investment, 202206 financing round Series A >$6.5m led by Karista	2022-06-20
Valneva–Pfizer: investment, 202206 equity investment via capital increase €90.5m (representing 8.1% if capital) at €9.49/share	2022-06-20
ImCheck Therapeutics–Agent Capital: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Agent Capital	2022-06-13
ImCheck Therapeutics–Alexandria Real Estate: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Alexandria VI	2022-06-13
ImCheck Therapeutics–Andera Partners: investment, 202206 financing round Series C totalling €80m incl new + co-lead investor Andera Partners	2022-06-13
ImCheck Therapeutics–Bellevue: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Pureos Bioventures	2022-06-13
ImCheck Therapeutics–Boehringer: investment, 202206 financing round Series C totalling €80m incl existing + co-investor BIVF	2022-06-13
ImCheck Therapeutics–Earlybird: investment, 202206 financing round Series C totalling €80m incl new + co-lead investor Earlybird	2022-06-13
ImCheck Therapeutics–EQT: investment, 202206 financing round Series C totalling €80m incl existing + co-investor EQT Life Sciences	2022-06-13
ImCheck Therapeutics–Eurazeo: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Eurazeo	2022-06-13
ImCheck Therapeutics–Eurazeo: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Kurma Partners GO Fund	2022-06-13
ImCheck Therapeutics–France (govt): investment, 202206 financing round Series C totalling €80m incl existing + co-investor Bpifrance Innobio 2 + LV	2022-06-13
ImCheck Therapeutics–Gimv: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Gimv	2022-06-13
ImCheck Therapeutics–Invus Group: investment, 202206 financing round Series C totalling €80m incl new + co-investor Invus	2022-06-13
ImCheck Therapeutics–Leukemia & Lymphoma Society: investment, 202206 financing round Series C totalling €80m incl new + co-investor LLS TAP	2022-06-13
ImCheck Therapeutics–Pfizer: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Pfizer Ventures	2022-06-13
ImCheck Therapeutics–SEVERAL: investment, 202206 financing round Series C €80m co-led by new investors Earlybird + Andera Partners	2022-06-13
ImCheck Therapeutics–Wellington Partners: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Wellington Partners	2022-06-13
Ariceum Therapeutics–Optimum Strategic Communications: public relations, 202206 service existent by Optimum	2022-06-08
Ariceum Therapeutics–SEVERAL: investment, 202206 financing round Series A €25m co-led by HealthCap + EQT Life Sciences	2022-06-08
Weezion–Mérieux: in-vitro diagnostics, 202206– collab technical assistance from bioMérieux to develop MS-based sepsis IVD	2022-06-01
Weezion–Mérieux: investment, 202206 investment €2m from bioMérieux for a 4.26% share accompanied by technical assistance	2022-06-01
Minoryx–SEVERAL: credit, 202205 complementary bank debt to Series C financing round (both tog totalling €51m)	2022-05-31
Minoryx–SEVERAL: investment, 202205 financing round Series C (incl complementary bank totalling €51m) led by Columbus VP + Caixa Capital Risc	2022-05-31
Repertoire Genesis–Eurofins: investment, 202205 acquisition of majority stake by Eurofins Scientific	2022-05-31
Advent Life Sciences–Scius Communications: public relations, 202205 supply service existent by Scius Communications	2022-05-26
Apollo Global Management–Sofinnova: life science financing, 202205– strategic partnership incl investm in Sofinnova Partners + up to $1b capital	2022-05-16
Sofinnova–Apollo Global Management: investment, 202205– acquisition of minority equity interest in Sofinnova Partners as part of strategic partnership	2022-05-16
Sofinnova–Apollo Global Management: investment, 202205– commitment of up to $1b managed capital to Sofinnova Partners investment funds by Apollo	2022-05-16
NanoPhoria–Sofinnova: investment, 202205 seed financing €3.5m from Sofinnova Telethon Fund	2022-05-12
Domain Therapeutics–BPCE: investment, 202205 financing round Series A totalling €39m incl existing + co-investor Seventure Partners	2022-05-10
Domain Therapeutics–Canada (govt): investment, 202205 financing round Series A totalling €39m incl co-investor adMare BioInnovations	2022-05-10
Domain Therapeutics–CTI Life Sciences: investment, 202205 financing round Series A totalling €39m incl co-lead investor CTI Life Sciences	2022-05-10
Domain Therapeutics–Helsinn: investment, 202205 financing round Series A totalling €39m incl co-lead investor 3B Future Health Fund	2022-05-10
Domain Therapeutics–Omnes Capital: investment, 202205 financing round Series A totalling €39m incl co-investor Omnes	2022-05-10
Domain Therapeutics–Panacea Venture: investment, 202205 financing round Series A totalling €39m incl co-lead investor Panacea Venture	2022-05-10
Domain Therapeutics–Schroders: investment, 202205 financing round Series A totalling €39m incl co-investor Schroders Capital	2022-05-10
Domain Therapeutics–SEVERAL: investment, 202205 financing round Series A €39m co-led by Panacea Venture + CTI Life Sciences + 3B Future Health Fund	2022-05-10
Domain Therapeutics–Theodorus: investment, 202205 financing round Series A totalling €39m incl co-investor Theodorus	2022-05-10
Domain Therapeutics–Turenne: investment, 202205 financing round Series A totalling €39m incl co-investor Turenne Capital/Sham Innovation Santé	2022-05-10
Domain Therapeutics–Viva Biotech: investment, 202205 financing round Series A totalling €39m incl co-investor Viva BioInnovator	2022-05-10
Tubulis–Andera Partners: investment, 202205 financing round Series B totalling €60m incl new + lead investor Andera Partners	2022-05-03
Tubulis–BPCE: investment, 202205 financing round Series B totalling €60m incl existing + co-investor Seventure Partners	2022-05-03
Tubulis–SEVERAL: investment, 202205 financing round Series B €60m led by new investor Andera Partners	2022-05-03
OMass–SEVERAL: investment, 202204 financing round Series B £75.5m led by new investors GV + Northpond Ventures + Sanofi Ventures	2022-04-28
Peak Proteins–Sygnature Discovery: investment, 202204 acquisition €na of Peak Proteins by Sygnature Discovery	2022-04-26
CDR-Life–Jeito Capital: investment, 202204 financing round Series A totalling $76m incl co-lead investor Jeito Capital	2022-04-13
CDR-Life–SEVERAL: investment, 202204 financing round Series A $76m co-led by Jeito Capital + RA Capital	2022-04-13
Ribonexus–France (govt): credit, 202204– repayable advance €1.4m via Future Investments Program from Bpifrance	2022-04-12
Ribonexus–France (govt): grant, 202204– grant €600k via Future Investments Program from Bpifrance	2022-04-12
Carmat–SEVERAL: investment, 202204 global offering €40.5m via issuance of 4.05m new shares	2022-04-11
LimFlow–Balestier: investment, 202204 financing round Series D totalling €36m incl existing investor Balestier family fund	2022-04-06
LimFlow–France (govt): investment, 202204 financing round Series D totalling €36m incl existing investor Bpifrance	2022-04-06
LimFlow–Longitude Capital: investment, 202204 financing round Series D totalling €36m incl new investor Longitude Capital	2022-04-06
LimFlow–OTHER: investment, 202204 financing round Series D totalling €36m incl new undisclosed strategic investor	2022-04-06
LimFlow–SEVERAL: investment, 202204 financing round Series D €36m with new + existing investors	2022-04-06
LimFlow–Sofinnova: investment, 202204 financing round Series D totalling €36m incl existing investor Sofinnova Partners	2022-04-06
LimFlow–Soleus Capital: investment, 202204 financing round Series D totalling €36m incl new investor Soleus Capital	2022-04-06
Bio-Medical Science–DNA Script: DNA synthesis system, 202204– distribution of Syntax EDS System by Bio-Medical Science in Korea	2022-04-05
Cold Spring Biotech–DNA Script: DNA synthesis system, 202204– distribution of Syntax EDS System by Cold Spring in China, Taiwan + Hong Kong	2022-04-05
Premas Life Sciences–DNA Script: DNA synthesis system, 202204– distribution of Syntax EDS System by Premas Life Sciences in India	2022-04-05
Research Instruments (SG)–DNA Script: DNA synthesis system, 202204– distribution of Syntax EDS System by Research Instruments in Singapore	2022-04-05
CardioRenal–SEVERAL: investment, 202204 seed financing round €3.3m from businses angels + management	2022-04-04
Axa–Canary Wharf Group: real estate, 202203– collab joint venture of Kadans Science Partner + CWG to built wet lab buliding in Canary Wharf London	2022-03-30
Core Biogenesis–Blue Horizon Ventures: investment, 202203 financing round Series A totalling €10m incl new + co-lead investor Blue Horizon Ventures	2022-03-29
Core Biogenesis–Entrepreneur First: investment, 202203 financing round Series A totalling €10m incl existing + co-investor Entrepreur First	2022-03-29
Core Biogenesis–OTHER: investment, 202203 financing round Series A totalling €10m incl business angels as investors	2022-03-29
Core Biogenesis–SEVERAL: investment, 202203 financing round Series A €10m led by XAnge + Blue Horizon Ventures	2022-03-29
Core Biogenesis–Siparex: investment, 202203 financing round Series A totalling €10m incl existing + co-lead investor XAnge	2022-03-29
Sanofi–IGM Biosciences: IgM antibody agonists, 202203– collab RnD + commerc ww excl $150m upfront + >$6b milestones for cancer + inflammation	2022-03-29

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)